Phathom Pharmaceuticals, Inc.
PHAT
$12.56
$0.030.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 180.90M | 129.97M | 135.16M | 149.57M | 212.32M |
| Total Receivables | 80.72M | 78.13M | 55.79M | 51.26M | 36.36M |
| Inventory | 6.51M | 5.52M | 3.61M | 3.43M | 3.17M |
| Prepaid Expenses | 8.44M | 15.35M | 13.23M | 14.62M | 13.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 276.57M | 228.97M | 207.78M | 218.88M | 264.90M |
|
|
|||||
| Total Current Assets | 276.57M | 228.97M | 207.78M | 218.88M | 264.90M |
| Net Property, Plant & Equipment | 3.52M | 3.67M | 3.85M | 2.12M | 1.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.03M | 26.51M | 28.66M | 29.23M | 27.57M |
| Total Assets | 305.12M | 259.15M | 240.29M | 250.22M | 294.21M |
|
|
|||||
| Total Accounts Payable | 6.37M | 4.98M | 1.08M | 4.01M | 11.62M |
| Total Accrued Expenses | 84.99M | 91.66M | 67.11M | 66.05M | 44.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 33.68M | 27.90M | 24.94M | 21.76M | 17.58M |
| Total Finance Division Other Current Liabilities | -- | 7.50M | -- | -- | -- |
| Total Other Current Liabilities | -- | 7.50M | -- | -- | -- |
| Total Current Liabilities | 125.04M | 132.04M | 93.12M | 91.82M | 74.03M |
|
|
|||||
| Total Current Liabilities | 125.04M | 132.04M | 93.12M | 91.82M | 74.03M |
| Long-Term Debt | 511.57M | 559.21M | 556.08M | 552.14M | 547.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.96M | 2.07M | 2.12M | 589.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.50M | 4.00M | 11.50M | 11.50M | 11.50M |
| Total Liabilities | 642.08M | 697.32M | 662.82M | 656.05M | 632.58M |
|
|
|||||
| Common Stock & APIC | 1.18B | 1.05B | 1.04B | 1.03B | 1.02B |
| Retained Earnings | -1.51B | -1.48B | -1.46B | -1.43B | -1.36B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -336.96M | -438.17M | -422.53M | -405.83M | -338.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -336.96M | -438.17M | -422.53M | -405.83M | -338.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -336.96M | -438.17M | -422.53M | -405.83M | -338.38M |
|
|
|||||